EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway

Frontiers in Oncology · 06.11.2026 · 16

DOI: 10.3389/fonc.2026.2038834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 06.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.2038834

Vancouver

Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.2038834

BibTeX
@article{euvimed2026,
  title = {Retraction: UBE2D3 activates SHP-2 ubiquitination to promote glycolysis and proliferation of glioma via regulating STAT3 signaling pathway},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.2038834}
}
Kostenlos starten →